Skip to content

Comparing of Atorvastatin and Rosuvastatin for reduce hscrp level and improving of lipid profile in patients with atherosclerotic cardiovascular disease who referred to angiography center of Kowsar hospital, Semnan

Comparing of Atorvastatin and Rosuvastatin for reduce hscrp level and improving of lipid profile in patients with atherosclerotic cardiovascular disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017080625732N24
Enrollment
60
Registered
2017-08-25
Start date
2017-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery. Coronary artery

Interventions

Intervention 1: Intervention group 1: 30 persons of patients are treated with atorvastatin (80 mg/daily) for 4 months and advice required for drug side effects will be given to patients that in the ev
Treatment - Drugs
Intervention group 1: 30 persons of patients are treated with atorvastatin (80 mg/daily) for 4 months and advice required for drug side effects will be given to patients that in the event of a possibl
Intervention group 2: 30 persons of patients are treated with rosuvastatin (40mg/daily) for 4 months and advice required for drug side effects will be given to patients that in the event of a possible

Sponsors

Deputy of Research and Technology, Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 69 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the age range of 50 to 70 years old; don’t have cancer; not be treated with immunosuppressive drugs such as corticosteroids; don’t have inflammation and rheumatologic diseases such as lupus and rheumatoid arthritis. Exclusion criteria: CASS for patients is zero; patients who cannot continue to experiment for any reasons in during 6 month follow up.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Coronary artery status. Timepoint: Before intervention, 4 months after intervention. Method of measurement: Angiography report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahbobeh Darban

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026